AbbVie Inc.
ABBV
$236.19
$2.331.00%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.23B | 2.39B | 3.76B | 4.20B | 4.28B |
| Total Depreciation and Amortization | 8.14B | 8.25B | 8.27B | 8.35B | 8.39B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.03B | 12.50B | 10.04B | 9.46B | 8.92B |
| Change in Net Operating Assets | -2.36B | -2.29B | -2.79B | -5.61B | -2.78B |
| Cash from Operations | 19.03B | 20.86B | 19.28B | 16.40B | 18.81B |
| Capital Expenditure | -1.21B | -1.18B | -1.04B | -1.02B | -974.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -5.44B | -6.07B | -11.76B | -11.67B | -20.52B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.00M | 194.00M | 761.00M | 715.00M | 671.00M |
| Cash from Investing | -6.64B | -7.05B | -12.05B | -11.97B | -20.82B |
| Total Debt Issued | 9.29B | 11.79B | 11.55B | 7.59B | 21.97B |
| Total Debt Repaid | -9.60B | -14.56B | -12.95B | -12.54B | -14.62B |
| Issuance of Common Stock | 172.00M | 134.00M | 138.00M | 143.00M | 214.00M |
| Repurchase of Common Stock | -980.00M | -1.34B | -1.35B | -1.35B | -1.71B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -11.66B | -11.50B | -11.34B | -11.18B | -11.03B |
| Other Financing Activities | 45.00M | 47.00M | 42.00M | 44.00M | -42.00M |
| Cash from Financing | -12.72B | -15.42B | -13.90B | -17.29B | -5.21B |
| Foreign Exchange rate Adjustments | 42.00M | -15.00M | 1.00M | -38.00M | -65.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -295.00M | -1.63B | -6.66B | -12.89B | -7.29B |